成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 31181-90-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 31181-90-5
Chemical Structure| 31181-90-5
Structure of 31181-90-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 31181-90-5 ]

Related Doc. of [ 31181-90-5 ]

Alternatived Products of [ 31181-90-5 ]
Product Citations

Product Citations

Nicholas O. Schneider ; Kendra Gilreath ; Daniel J. Burkett , et al. DOI:

Abstract: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase which plays a center role in the phosphorylation of a wide variety of proteins, generally leading to their inactivation. As such, GSK-3 is viewed as a therapeutic target. An ever-increasing number of small organic molecule inhibitors of GSK-3 have been reported. Phenylmethylene hydantoins are known to exhibit a wide range of inhibitory activities including for GSK-3β. A family of fourteen 2-heterocycle substituted methylene hydantoins (14, 17–29) were prepared and evaluated for the inhibition of GSK-3β at 25 μM. The IC50 values of five of these compounds was determined; the two best inhibitors are 5-[(4′-chloro-2-pyridinyl)methylene]hydantoin (IC50 = 2.14 ± 0.18 μM) and 5-[(6′-bromo-2-pyridinyl)methylene]hydantoin (IC50 = 3.39 ± 0.16 μM). The computational docking of the compounds with GSK-3β (pdb 1q41) revealed poses with hydrogen bonding to the backbone at Val135. The 5-[(heteroaryl)methylene]hydantoins did not strongly inhibit other metalloenzymes, demonstrating poor inhibitory activity against matrix metalloproteinase-12 at 25 μM and against human carbonic anhydrase at 200 μM, and were not inhibitors for Staphylococcus aureus pyruvate carboxylase at concentrations >1000 μM.

Keywords: nitrogen heterocycles ; glycogen synthase kinase 3β ; computational docking

Purchased from AmBeed: ; ; ; ; ; ; ; ; ;

Product Details of [ 31181-90-5 ]

CAS No. :31181-90-5 MDL No. :MFCD04112535
Formula : C6H4BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :ZQVLPMNLLKGGIU-UHFFFAOYSA-N
M.W : 186.01 Pubchem ID :9877562
Synonyms :

Calculated chemistry of [ 31181-90-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 37.32
TPSA : 29.96 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.48 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.13
Log Po/w (XLOGP3) : 1.34
Log Po/w (WLOGP) : 1.66
Log Po/w (MLOGP) : 0.56
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 1.38

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.26
Solubility : 1.01 mg/ml ; 0.00544 mol/l
Class : Soluble
Log S (Ali) : -1.57
Solubility : 5.0 mg/ml ; 0.0269 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.83
Solubility : 0.278 mg/ml ; 0.00149 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.2

Safety of [ 31181-90-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 31181-90-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 31181-90-5 ]

[ 31181-90-5 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 31181-90-5 ]
  • [ 845827-13-6 ]
YieldReaction ConditionsOperation in experiment
74% With (bis-(2-methoxyethyl)amino)sulfur trufluoride; In dichloromethane; at 45℃; for 16h; Dissolve 5-bromopyridine-2-carboxaldehyde (10.0 g, 53.76 mmol) in DCM (200 mL). Add bis(2-methoxyethyl)aminosulfur trifluoride (39 g, 134.4 mmol) slowly. Heat the resulting solution to 45 C. and stir for 16 hours. Pour the reaction slowly into ice water (50 mL). Adjust the pH of the solution to 7 with a saturated NaHCO3 aqueous solution. Extract the aqueous solution with DCM (3*20 mL). Dry the combined organic extracts over sodium sulfate; filter; collect the filtrate; and concentrate the filtrate under reduced pressure. Purify the residue by flash chromatography eluting with a 4:1 ratio of petroleum ether to EtOAc to give the title compound (8.5 g, 74% yield) as a yellow liquid. 1H NMR (300 MHz, CDCl3) delta 8.73 (d, J=2.4 Hz, 1H), 8.00 (dd, J=2.4, 8.1 Hz, 1H), 7.56 (d, J=8.1 Hz, 1H), 6.44-6.80 (t, J=54.9 Hz, 1 Hz).
67% With diethylamino-sulfur trifluoride; In dichloromethane; at -78 - 20℃; for 6h; To a cooled solution of 5-bromopyridine-2-carbaldehyde (A) (7.0 g, 38 mmol) in CH2Cl2 (300 mL) at -78 C. was added diethylaminosulfur trifluoride (DAST, 10.8 mL, 83 mmol). The reaction was allowed to warm to room temperature over the course of 6 h, then it was quenched slowly with H2O, washed with saturated aqueous NaHCO3 and dried over Na2SO4. Concentration and purification by silica gel plug (CH2Cl2 eluent) furnished 5-bromo-2-difluoromethylpyridine (B) as brown crystals (5.3g, 67%). 1H NMR (300 MHz, CDCl3) delta 8.8 (s, 1H), 8.0 (d, 1H), 7.6 (d, 1H), 6.6 (t, 1H).
67% With diethylamino-sulfur trifluoride; In dichloromethane; at -78 - 20℃; for 6h; To a cooled solution of 5-bromopyridine-2-carbaldehyde (A) (7.0 g, 38 mmol) in CH2Cl2 (300 mL) at -78 C. was added diethylaminosulfur trifluoride (DAST, 10.8 mL, 83 mmol). The reaction was allowed to warm to room temperature over the course of 6 h, then it was quenched slowly with H2O, washed with saturated aqueous NaHCO3 and dried over Na2SO4. Concentration and purification by silica gel plug (CH2Cl2 eluent) furnished 5-bromo-2-difluoromethylpyridine (B) as brown crystals (5.3 g, 67 percent). 1H NMR (300 MHz, CDCl3) delta 8.8 (s, 1H), 8.0 (d, 1H), 7.6 (d, 1H), 6.6 (t, 1H).
67% With diethylamino-sulfur trifluoride; In dichloromethane; at -78 - 20℃; for 6h; To a cooled solution of 5-bromopyridine-2-carbaldehyde (A) (7.0 g, 38 mmol) in CH2Cl2 (300 mL) at -78 C. was added diethylaminosulfur trifluoride (DAST, 10.8 mL, 83 mmol). The reaction was allowed to warm to room temperature over the course of 6 h, then it was quenched slowly with H2O, washed with saturated aqueous NaHCO3 and dried over Na2SO4. Concentration and purification by silica gel plug (CH2Cl2 eluent) furnished 5-bromo-2-difluoromethylpyridine (B) as brown crystals (5.3 g, 67 percent). 1H NMR (300 MHz, CDCl3) delta 8.8 (s, 1H), 8.0 (d, 1H), 7.6 (d, 1H), 6.6 (t, 1H).
67% To a cooled solution of 5-bromopyridine-2-carbaldehyde (A) (7.0 g, 38 mmol) in CH2Cl2 (300 mL) at -78 C. was added diethylaminosulfur trifluoride (DAST, 10.8 mL, 83 mmol). The reaction was allowed to warm to room temperature over the course of 6 h, then it was quenched slowly with H2O, washed with saturated aqueous NaHCO3 and dried over Na2SO4. Concentration and purification by silica gel plug (CH2Cl2 eluent) furnished 5-bromo-2-difluoromethylpyridine (B) as brown crystals (5.3 g, 67%). 1H NMR (300 MHz, CDCl3) delta 8.8 (s, 1H), 8.0 (d, 1H), 7.6 (d, 1H), 6.6 (t, 1H).
63% With diethylamino-sulfur trifluoride; In dichloromethane; at -78 - 20℃; for 6h; To a cooled solution of 5-bromopyridine-2-carbaldehyde (A) (7.0 g, 38 mmol) in CH2Cl2 (300 mL) at -78 C. was added diethylaminosulfur trifluoride (DAST, 10.8 mL, 83 mmol). The reaction was allowed to warm to room temperature over the course of 6 h, then it was quenched slowly with H2O, washed with saturated aqueous NaHCO3 and dried over Na2SO4. Concentration and purification by silica gel plug (CH2Cl2 eluent) furnished 5-bromo-2-difluoromethylpyridine (B) as brown crystals (5.3 g, 67%). 1H NMR (300 MHz, CDCl3) delta 8.8 (s, 1H), 8.0 (d, 1H), 7.6 (d, 1H), 6.6 (t, 1H).
54% With diethylamino-sulfur trifluoride; In dichloromethane; at 0 - 20℃; for 12h; Into a 2000-mL 4-necked round-bottom flask, was placed a solution of 5-bromopyridine-2- carbaldehyde (30 g, 161 .29 mmol, 1.00 equiv) in dichloromethane (800 mL). This was followed by the addition of DAST (diethylaminosulfur trifluoride) (40 g, 1 .08 mol, 6.69 equiv) dropwise with stirring at 0C. The resulting solution was stirred for 12 hours at room temperature. The reaction was then quenched by the addition of water. The pH value of the solution wasadjusted to 8 with sodium carbonate (2 mol/L). The resulting solution was extracted with 3x500 mL of dichloromethane and the organic layers were combined. The resulting mixture was washed with 1x300 mL of H20. The resulting mixture was washed with 1x300 mL of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1:10). Thisresulted in 18 g (54%) of 5-bromo-2-(difluoromethyl)pyridine as yellow oil.
54% With diethylamino-sulfur trifluoride; In dichloromethane; at -78 - 20℃; for 5h; A stirred solution of 5-bromo-2-picolinaldehyde (10 g, 54 mmol) (Org. Lett. 2004, 6,4905) in dry CH2Cl2 (100 mL) at -78 0C was treated with DAST (9.2 g, 70 mmol) and the resulting reaction mixture was allowed to warm to room temperature over a period 5h. After completion of the reaction, the reaction mixture was quenched by ice-cold water and extracted with CH2Cl2. The organic layer was dried over anhydrous Na2SO4 and the solvents were evaporated in vacuo. The residue was purified by column chromatography (SiO2, 5% Et2O/pet. ether) to afford the title compound (6 g, 54% yield). MS: 210 [M+l]+; 1H-NMR (300 MHz, CDCl3): delta 8.72 (s, IH), 7.93 (d, IH, J= 8.3Hz), 7.54 (d, IH, J= 8.3Hz), 6.60 (t, IH, J= 55.1Hz).
54% With diethylamino-sulfur trifluoride; In dichloromethane; at 0 - 20℃; for 12h; Into a 2000-mL 4-necked round-bottom flask, was placed a solution of 5-bromopyridine-2- carbaldehyde (30 g, 161.29 mmol, 1.00 equiv) in dichloromethane (800 mL). This was followed by the addition of DAST (diethylaminosulfur trifluoride) (40 g, 1.08 mol, 6.69 equiv) dropwise with stirring at 0C. The resulting solution was stirred for 12 hours at room temperature. The reaction was then quenched by the addition of water. The pH value of the solution was adjusted to 8 with sodium carbonate (2 mol/L). The resulting solution was extracted with 3x500 ml. of dichloromethane and the organic layers were combined. The resulting mixture was washed with 1x300 ml. of water. The resulting mixture was washed with 1x300 ml. of brine. The mixture was dried over anhydrous sodium sulfate and concentrated under vacuum. The residue was applied onto a silica gel column with ethyl acetate/petroleum ether (1 :10). This resulted in 18 g (54%) of 5-bromo-2-(difluoromethyl)pyridine as yellow oil.
36% With (bis-(2-methoxyethyl)amino)sulfur trufluoride; In ethanol; dichloromethane; at 0 - 23℃; for 18h; Example 32 Preparation of 5-bromo-2-(difluoromethyl)pyridine Deoxofluor (1.7 mL, 9.1 mmol, 1.7 equiv) and ethanol (63 muL, 1.1 mmol, 0.20 equiv) were sequentially added to a stirred solution of 5-bromopicolinaldehyde (1.0 g, 5.4 mmol, 1.0 equiv) in dichloromethane (5.4 mL) at 0 C. The resulting orange solution was allowed to slowly warm to 23 C. and stirred for 18 h. The dark brown reaction mixture was quenched with saturated sodium bicarbonate solution (6 mL) and stirred at 23 C. for 1 h. The reaction mixture was diluted with water (100 mL) and extracted with dichloromethane (3*50 mL). The combined organic layers were washed with 0.1M HCl (1*150 mL), dried (MgSO4), gravity filtered, and concentrated by rotary evaporation to afford the title compound as a brown semisolid (400 mg, 36%): IR (thin film) 3051 (m), 2925 (s), 2853 (m), 1641 (w) cm-1; 1H NMR (300 MHz, CDCl3) delta 8.72 (d, J=2 Hz, 1H), 7.98 (dd, J=8, 2 Hz, 1H), 7.55 (d, J=8 Hz, 1H), 6.61 (t, J=55 Hz, 1H).
With diethylamino-sulfur trifluoride; In chloroform; at 0 - 20℃; A solution of 5-bromo-pyridine-2-carbaldehyde (1.0 mmol) in dry chloroform (5 mL) is cooled to 00C and N,Lambda/-diethylaminosulfur trifluoride (2.0 mmol) is slowly added under vigorous stirring. The reaction mixture is reacted 5 minutes at 00C and is then allowed to reach room temperature and is further stirred at this temperature overnight. The reaction is diluted by the addition of chloroform (15 mL), an aqueous saturated sodium carbonate solution (10 mL) is added drop wise and the resulting mixture is stirred for 10 minutes. The organic phase is collected and washed with water (10 mL), brine (10 mL), is dried over magnesium sulphate, filtered and concentrated under reduced pressure to afford the desired product which is used in the next step without further purification.
1.06 g 1 g 5-Bromo-pyridine-2-carboxaldehyde was dissolved in 50 mL DCM. The solution was cooled to -70C, then 1.55 mL diethylaminosulfurtrifluoride was added dropwise over 20 minutes. The suspension was stirred for 30 minutes at room temperature, then 10 mL water was added at 0C followed by slow addition of 20 mL saturated NaHC03 (gas formation). The phases were separated and 2 mL of 4N HC1 in dioxane is added to the organic phase which was concentrated in vacuo to provide 1.06 g product as yellow solid. HPLC-MS: Rt = 0.72 min (method X001 004), M+H =208 / 210.
1.06 g With hydrogenchloride; diethylamino-sulfur trifluoride; In dichloromethane; at -70 - 20℃; for 0.833333h; 5-Bromo-2-(difluoromethyl)pyridine for Example 120 1 g 5-Bromo-pyridine-2-carboxaldehyde was dissolved in 50 mL DCM. The solution was cooled to -70 C., then 1.55 mL diethylaminosulfurtrifluoride was added dropwise over 20 minutes. The suspension was stirred for 30 minutes at room temperature, then 10 mL water was added at 0 C. followed by slow addition of 20 mL saturated NaHCO3 (gas formation). The phases were separated and 2 mL of 4N HCl in dioxane is added to the organic phase which was concentrated in vacuo to provide 1.06 g product as yellow solid. HPLC-MS: Rt=0.72 min (method X001-004), M+H=208/210.
1.06 g With diethylamino-sulfur trifluoride; In dichloromethane; at -70 - 20℃; for 0.833333h; Synthesis of 5-Bromo-2-(difluoromethyl)pyridine 3.3A solution of 1 g of 5-bromopyridine-2-carbaldehyde in 50 mL DCM was cooled to -70C, then 1 .55 mL diethylaminosulfurtrifluoride were added dropwise over 20 minutes. The suspension was stirred for 30 minutes at room temperature, then 10 mL water were added at 0C followed by slow addition of 20 mL saturated NaHC03 (gas formation). The phases were separated and 2 mL of 4M HCI in dioxane were added to the organic phase which was concentrated in vacuo to provide 1.06 g product as yellow solid. Analysis: HPLC-MS: Rt = 0.72 min (method D), M+H =208 / 210.

  • 2
  • [ 31181-90-5 ]
  • [ 163520-14-7 ]
  • [ 956316-47-5 ]
  • 3
  • [ 7504-94-1 ]
  • [ 31181-90-5 ]
  • [ 1333991-73-3 ]
  • 4
  • [ 31181-90-5 ]
  • [ 103291-07-2 ]
  • [ 1357563-99-5 ]
YieldReaction ConditionsOperation in experiment
To a solution of <strong>[103291-07-2]5-bromo-2-fluoroanisole</strong> (1.00 g, 4.88 mmol, 1 equiv) in anhydrous THF was added granules of magnesium (125 mg, 5.12 mmol, 1.05 equiv) under nitrogen. The mixture was heated to 60 C for 2 h. After cooling to room temperature, 5-bromo-2-formylpyridine (1.09 g, 5.86 mmol, 1.2 equiv) was added and the reaction mixture was stirred at 80 C overnight. The reaction was cooled to room temperature, quenched with brine and the aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over sodium sulfate, filtered and concentrated to dryness under vacuum. The product was used in the next step without further purification. C13H11BrFNO2; MW 312.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 31181-90-5 ]

Bromides

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.90

Chemical Structure| 214701-49-2

[ 214701-49-2 ]

1-(5-Bromopyridin-2-yl)ethanone

Similarity: 0.88

Chemical Structure| 1289168-19-9

[ 1289168-19-9 ]

3-Amino-5-bromopicolinaldehyde

Similarity: 0.85

Chemical Structure| 3430-13-5

[ 3430-13-5 ]

5-Bromo-2-methylpyridine

Similarity: 0.85

Chemical Structure| 131747-63-2

[ 131747-63-2 ]

4-Bromopicolinaldehyde

Similarity: 0.84

Aldehydes

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.90

Chemical Structure| 1289168-19-9

[ 1289168-19-9 ]

3-Amino-5-bromopicolinaldehyde

Similarity: 0.85

Chemical Structure| 131747-63-2

[ 131747-63-2 ]

4-Bromopicolinaldehyde

Similarity: 0.84

Chemical Structure| 137778-18-8

[ 137778-18-8 ]

5-Bromo-6-methylpicolinaldehyde

Similarity: 0.84

Chemical Structure| 1121-60-4

[ 1121-60-4 ]

2-Pyridinecarboxaldehyde

Similarity: 0.78

Related Parent Nucleus of
[ 31181-90-5 ]

Pyridines

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.90

Chemical Structure| 214701-49-2

[ 214701-49-2 ]

1-(5-Bromopyridin-2-yl)ethanone

Similarity: 0.88

Chemical Structure| 1289168-19-9

[ 1289168-19-9 ]

3-Amino-5-bromopicolinaldehyde

Similarity: 0.85

Chemical Structure| 3430-13-5

[ 3430-13-5 ]

5-Bromo-2-methylpyridine

Similarity: 0.85

Chemical Structure| 131747-63-2

[ 131747-63-2 ]

4-Bromopicolinaldehyde

Similarity: 0.84

; ;